Switzerland Biotechnology & Medical Research

BeOne Medicines AG (688235)

Track

Track

BeOne Medicines AG experienced significant insider trading activity recently, with 85 transactions totaling over $311 million in sales. Chair Wang Xiaodong led these divestments, primarily through planned sales. This selling pressure follows a period where the stock price declined 1.3% and the company reported a 5.56% earnings report miss.
Ticker: 688235 Exchange: SHH
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
385.52
Quantity 84,936 +26.6%
Value US$4,037,125
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
186.62
Quantity 45,421 -5.8%
Value US$2,590,543
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
262.41
Quantity 98,940 -4.5%
Value US$1,909,518
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
350.47
Quantity 1,000 -43.4%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
349.56
Quantity 1,000 -23.1%
Value US$100,000
Lee Chan Henry SVP, General Counsel Officer
Transaction date
Planned sale
Price
375.00
Quantity 1,000 -100.0%
Value US$100,000
CHAN LEE Officer Officer
Transaction date
Proposed sale
Price
365.27
Quantity 1,000
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
367.23
Quantity 1,000 -100.0%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
366.58
Quantity 1,000 -95.2%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
365.85
Quantity 1,000 -11.8%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
364.07
Quantity 1,000 -16.5%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
363.10
Quantity 1,000 -14.4%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
362.17
Quantity 1,000 -14.9%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
361.05
Quantity 1,000 -7.3%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
359.16
Quantity 1,000 -0.1%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
358.71
Quantity 1,000 -0.4%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
356.97
Quantity 1,000 -0.5%
Value US$100,000
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
351.25
Quantity 6,278 -100.0%
Value US$2,205,174
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
351.25
Quantity 6,278 -100.0%
Value US$2,205,174
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
350.27
Quantity 6,569 -51.1%
Value US$2,300,951
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
350.27
Quantity 6,569 -51.1%
Value US$2,300,951
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
349.28
Quantity 10,688 -45.4%
Value US$3,733,141
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
349.28
Quantity 10,688 -45.4%
Value US$3,733,141
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
348.31
Quantity 7,492 -24.1%
Value US$2,609,573
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
348.31
Quantity 7,492 -24.1%
Value US$2,609,573
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
348.01
Quantity 1,721 -100.0%
Value US$598,930
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
347.39
Quantity 1,517 -46.8%
Value US$526,993
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
347.39
Quantity 1,517 -46.8%
Value US$526,993
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
346.16
Quantity 2,841 -46.7%
Value US$983,433
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
346.16
Quantity 2,841 -46.7%
Value US$983,433
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
345.38
Quantity 1,181 -16.3%
Value US$407,897
Wang Xiaodong Chair, Scientific Advisory Brd Non-Executive Director
Transaction date
Planned sale
Price
345.38
Quantity 1,181 -16.3%
Value US$407,897
XIAODONG WANG Director; Chair; Scientific Advisory Brd Non-Executive Director
Transaction date
Proposed sale
Price
358.26
Quantity 131,370
Value US$47,064,616
Ball Titus B. Principal Accounting Officer Officer
Transaction date
Sale
Price
355.86
Quantity 132 -100.0%
Value US$46,974
TITUS BENJAMIN BALL Officer Officer
Transaction date
Proposed sale
Price
355.86
Quantity 132
Value US$46,974
Wu Xiaobin President and COO Officer
Transaction date
Planned sale
Price
380.00
Quantity 280 -100.0%
Value US$106,400
XIAOBIN WU Officer Officer
Transaction date
Proposed sale
Price
371.98
Quantity 15,000
Value US$5,579,700
2.9
CORAZON D. SANDERS Former Director Non-Executive Director
Transaction date
Proposed sale
Price
380.00
Quantity 2,075
Value US$788,500
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
359.12
Quantity 14,102 -100.0%
Value US$5,064,252
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
358.41
Quantity 20,899 -59.7%
Value US$7,490,448
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
357.63
Quantity 15,396 -30.5%
Value US$5,506,147
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
356.43
Quantity 2,515 -4.8%
Value US$896,426
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
354.71
Quantity 1,980 -3.6%
Value US$702,320
Lee Chan Henry SVP, General Counsel Officer
Transaction date
Planned sale
Price
360.00
Quantity 2,666 -100.0%
Value US$959,760
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
367.00
Quantity 4 -0.0%
Value US$1,468
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
366.31
Quantity 1,200 -2.1%
Value US$439,574
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
365.26
Quantity 3,176 -5.4%
Value US$1,160,079
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
364.31
Quantity 5,211 -8.1%
Value US$1,898,442
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
363.45
Quantity 13,403 -17.2%
Value US$4,871,344
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
362.34
Quantity 11,568 -12.9%
Value US$4,191,548
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
361.47
Quantity 14,569 -14.0%
Value US$5,266,268
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
360.33
Quantity 8,081 -7.2%
Value US$2,911,849
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
359.32
Quantity 13,695 -10.9%
Value US$4,920,844
CHAN LEE Officer Officer
Transaction date
Proposed sale
Price
359.00
Quantity 2,002
Value US$718,718
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
360.63
Quantity 3,680 -2.8%
Value US$1,327,130
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
359.50
Quantity 21,254 -14.1%
Value US$7,640,826
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
358.70
Quantity 45,044 -23.0%
Value US$16,157,076
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
357.67
Quantity 15,869 -7.5%
Value US$5,675,864
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
356.62
Quantity 12,418 -5.5%
Value US$4,428,482
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
355.66
Quantity 3,476 -1.5%
Value US$1,236,261
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
354.78
Quantity 6,717 -2.9%
Value US$2,383,028
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
353.32
Quantity 3,673 -1.5%
Value US$1,297,741
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
351.80
Quantity 2,813 -1.2%
Value US$989,603
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
350.00
Quantity 67 -0.0%
Value US$23,450
JOHN V OYLER Director; Officer Executive Director
Transaction date
Proposed sale
Price
348.27
Quantity 240,810
Value US$83,866,899
Rosenberg Aaron Chief Financial Officer Officer
Transaction date
Sale
Price
312.72
Quantity 1,157 -100.0%
Value US$361,811
AARON ROSENBERG Officer Officer
Transaction date
Proposed sale
Price
312.72
Quantity 1,157
Value US$361,811
Lee Chan Henry SVP, General Counsel Officer
Transaction date
Sale
Price
323.69
Quantity 1,044 -100.0%
Value US$337,932
CHAN LEE Officer Officer
Transaction date
Proposed sale
Price
323.69
Quantity 1,044
Value US$337,932
Lee Chan Henry SVP, General Counsel Officer
Transaction date
Planned sale
Price
325.00
Quantity 1,669 -100.0%
Value US$542,425
CHAN LEE Officer Officer
Transaction date
Proposed sale
Price
318.69
Quantity 2,001
Value US$637,689
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
320.06
Quantity 2,340 -100.0%
Value US$748,936
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
319.29
Quantity 15,807 -87.1%
Value US$5,047,019
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
318.41
Quantity 7,842 -30.2%
Value US$2,496,997
OYLER JOHN Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
316.91
Quantity 20,029 -43.5%
Value US$6,347,340
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-15 2026-10-13 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
84,936 +26.6%
385.52
US$4,037,125 		84,936 +26.6% 385.52 US$4,037,125
2026-10-15 2026-10-13 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
45,421 -5.8%
186.62
US$2,590,543 		45,421 -5.8% 186.62 US$2,590,543
2026-10-15 2026-10-13 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
98,940 -4.5%
262.41
US$1,909,518 		98,940 -4.5% 262.41 US$1,909,518
2026-10-15 2026-10-13 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -43.4%
350.47
US$100,000 		1,000 -43.4% 350.47 US$100,000
2026-10-15 2026-10-13 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -23.1%
349.56
US$100,000 		1,000 -23.1% 349.56 US$100,000
2026-10-02 2026-09-30 PlS Planned sale
Lee Chan Henry

SVP, General Counsel

Officer
1,000 -100.0%
375.00
US$100,000 		1,000 -100.0% 375.00 US$100,000
2026-09-30 2026-09-30 PrS Proposed sale
CHAN LEE

Officer

Officer
1,000
365.27
US$100,000 		1,000 365.27 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -100.0%
367.23
US$100,000 		1,000 -100.0% 367.23 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -95.2%
366.58
US$100,000 		1,000 -95.2% 366.58 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -11.8%
365.85
US$100,000 		1,000 -11.8% 365.85 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -16.5%
364.07
US$100,000 		1,000 -16.5% 364.07 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -14.4%
363.10
US$100,000 		1,000 -14.4% 363.10 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -14.9%
362.17
US$100,000 		1,000 -14.9% 362.17 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -7.3%
361.05
US$100,000 		1,000 -7.3% 361.05 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -0.1%
359.16
US$100,000 		1,000 -0.1% 359.16 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -0.4%
358.71
US$100,000 		1,000 -0.4% 358.71 US$100,000
2026-09-30 2026-09-28 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,000 -0.5%
356.97
US$100,000 		1,000 -0.5% 356.97 US$100,000
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
6,278 -100.0%
351.25
US$2,205,174 		6,278 -100.0% 351.25 US$2,205,174
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
6,278 -100.0%
351.25
US$2,205,174 		6,278 -100.0% 351.25 US$2,205,174
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
6,569 -51.1%
350.27
US$2,300,951 		6,569 -51.1% 350.27 US$2,300,951
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
6,569 -51.1%
350.27
US$2,300,951 		6,569 -51.1% 350.27 US$2,300,951
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
10,688 -45.4%
349.28
US$3,733,141 		10,688 -45.4% 349.28 US$3,733,141
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
10,688 -45.4%
349.28
US$3,733,141 		10,688 -45.4% 349.28 US$3,733,141
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
7,492 -24.1%
348.31
US$2,609,573 		7,492 -24.1% 348.31 US$2,609,573
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
7,492 -24.1%
348.31
US$2,609,573 		7,492 -24.1% 348.31 US$2,609,573
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,721 -100.0%
348.01
US$598,930 		1,721 -100.0% 348.01 US$598,930
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,517 -46.8%
347.39
US$526,993 		1,517 -46.8% 347.39 US$526,993
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,517 -46.8%
347.39
US$526,993 		1,517 -46.8% 347.39 US$526,993
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
2,841 -46.7%
346.16
US$983,433 		2,841 -46.7% 346.16 US$983,433
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
2,841 -46.7%
346.16
US$983,433 		2,841 -46.7% 346.16 US$983,433
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,181 -16.3%
345.38
US$407,897 		1,181 -16.3% 345.38 US$407,897
2026-09-10 2026-09-08 PlS Planned sale
Wang Xiaodong

Chair, Scientific Advisory Brd

Non-Executive Director
1,181 -16.3%
345.38
US$407,897 		1,181 -16.3% 345.38 US$407,897
2026-09-08 2026-09-08 PrS Proposed sale
XIAODONG WANG

Director; Chair; Scientific Advisory Brd

Non-Executive Director
131,370
358.26
US$47,064,616 		131,370 358.26 US$47,064,616
2026-09-03 2026-09-01 S Sale
Ball Titus B.

Principal Accounting Officer

Officer
132 -100.0%
355.86
US$46,974 		132 -100.0% 355.86 US$46,974
2026-09-01 2026-09-01 PrS Proposed sale
TITUS BENJAMIN BALL

Officer

Officer
132
355.86
US$46,974 		132 355.86 US$46,974
2026-08-27 2026-08-25 PlS Planned sale
Wu Xiaobin

President and COO

Officer
280 -100.0%
380.00
US$106,400 		280 -100.0% 380.00 US$106,400
2026-08-25 2026-08-25 PrS Proposed sale
XIAOBIN WU

Officer

Officer
15,000
371.98
US$5,579,700 		15,000 371.98 US$5,579,700
2026-08-25 2026-08-25 PrS Proposed sale
2.9
CORAZON D. SANDERS

Former Director

Non-Executive Director
2,075
380.00
US$788,500 		2,075 380.00 US$788,500
2026-08-12 2026-08-12 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
14,102 -100.0%
359.12
US$5,064,252 		14,102 -100.0% 359.12 US$5,064,252
2026-08-12 2026-08-12 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
20,899 -59.7%
358.41
US$7,490,448 		20,899 -59.7% 358.41 US$7,490,448
2026-08-12 2026-08-12 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
15,396 -30.5%
357.63
US$5,506,147 		15,396 -30.5% 357.63 US$5,506,147
2026-08-12 2026-08-12 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
2,515 -4.8%
356.43
US$896,426 		2,515 -4.8% 356.43 US$896,426
2026-08-12 2026-08-12 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
1,980 -3.6%
354.71
US$702,320 		1,980 -3.6% 354.71 US$702,320
2026-08-13 2026-08-11 PlS Planned sale
Lee Chan Henry

SVP, General Counsel

Officer
2,666 -100.0%
360.00
US$959,760 		2,666 -100.0% 360.00 US$959,760
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
4 -0.0%
367.00
US$1,468 		4 -0.0% 367.00 US$1,468
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
1,200 -2.1%
366.31
US$439,574 		1,200 -2.1% 366.31 US$439,574
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
3,176 -5.4%
365.26
US$1,160,079 		3,176 -5.4% 365.26 US$1,160,079
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
5,211 -8.1%
364.31
US$1,898,442 		5,211 -8.1% 364.31 US$1,898,442
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
13,403 -17.2%
363.45
US$4,871,344 		13,403 -17.2% 363.45 US$4,871,344
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
11,568 -12.9%
362.34
US$4,191,548 		11,568 -12.9% 362.34 US$4,191,548
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
14,569 -14.0%
361.47
US$5,266,268 		14,569 -14.0% 361.47 US$5,266,268
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
8,081 -7.2%
360.33
US$2,911,849 		8,081 -7.2% 360.33 US$2,911,849
2026-08-12 2026-08-11 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
13,695 -10.9%
359.32
US$4,920,844 		13,695 -10.9% 359.32 US$4,920,844
2026-08-11 2026-08-11 PrS Proposed sale
CHAN LEE

Officer

Officer
2,002
359.00
US$718,718 		2,002 359.00 US$718,718
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
3,680 -2.8%
360.63
US$1,327,130 		3,680 -2.8% 360.63 US$1,327,130
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
21,254 -14.1%
359.50
US$7,640,826 		21,254 -14.1% 359.50 US$7,640,826
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
45,044 -23.0%
358.70
US$16,157,076 		45,044 -23.0% 358.70 US$16,157,076
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
15,869 -7.5%
357.67
US$5,675,864 		15,869 -7.5% 357.67 US$5,675,864
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
12,418 -5.5%
356.62
US$4,428,482 		12,418 -5.5% 356.62 US$4,428,482
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
3,476 -1.5%
355.66
US$1,236,261 		3,476 -1.5% 355.66 US$1,236,261
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
6,717 -2.9%
354.78
US$2,383,028 		6,717 -2.9% 354.78 US$2,383,028
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
3,673 -1.5%
353.32
US$1,297,741 		3,673 -1.5% 353.32 US$1,297,741
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
2,813 -1.2%
351.80
US$989,603 		2,813 -1.2% 351.80 US$989,603
2026-08-12 2026-08-10 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
67 -0.0%
350.00
US$23,450 		67 -0.0% 350.00 US$23,450
2026-08-10 2026-08-10 PrS Proposed sale
JOHN V OYLER

Director; Officer

Executive Director
240,810
348.27
US$83,866,899 		240,810 348.27 US$83,866,899
2026-08-05 2026-08-03 S Sale
Rosenberg Aaron

Chief Financial Officer

Officer
1,157 -100.0%
312.72
US$361,811 		1,157 -100.0% 312.72 US$361,811
2026-08-03 2026-08-03 PrS Proposed sale
AARON ROSENBERG

Officer

Officer
1,157
312.72
US$361,811 		1,157 312.72 US$361,811
2026-08-03 2026-07-30 S Sale
Lee Chan Henry

SVP, General Counsel

Officer
1,044 -100.0%
323.69
US$337,932 		1,044 -100.0% 323.69 US$337,932
2026-07-30 2026-07-30 PrS Proposed sale
CHAN LEE

Officer

Officer
1,044
323.69
US$337,932 		1,044 323.69 US$337,932
2026-07-24 2026-07-22 PlS Planned sale
Lee Chan Henry

SVP, General Counsel

Officer
1,669 -100.0%
325.00
US$542,425 		1,669 -100.0% 325.00 US$542,425
2026-07-22 2026-07-22 PrS Proposed sale
CHAN LEE

Officer

Officer
2,001
318.69
US$637,689 		2,001 318.69 US$637,689
2026-07-22 2026-07-21 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
2,340 -100.0%
320.06
US$748,936 		2,340 -100.0% 320.06 US$748,936
2026-07-22 2026-07-21 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
15,807 -87.1%
319.29
US$5,047,019 		15,807 -87.1% 319.29 US$5,047,019
2026-07-22 2026-07-21 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
7,842 -30.2%
318.41
US$2,496,997 		7,842 -30.2% 318.41 US$2,496,997
2026-07-22 2026-07-21 PlS Planned sale
OYLER JOHN

Chief Executive Officer

Executive Director
20,029 -43.5%
316.91
US$6,347,340 		20,029 -43.5% 316.91 US$6,347,340
Explore more

More insider trading research around BeOne Medicines AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe